Internal standard strategies for relative and absolute quantitation of peptides in biological matrices by liquid chromatography tandem mass spectrometry

Biomedical Chromatography

Volumn 26, Issue 8, 2012, Pages 881-891

  Pailleux, Floriane ^a,b   Beaudry, Francis ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Institut des Sciences Analytiques   (France)

Author keywords

Bioanalysis; Biomarker; Internal stardard; Isotopic labeling; Liquid chromatography; Mass spectrometry; Peptidomic

Indexed keywords

DIAGNOSIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROGRAM DIAGNOSTICS;

BIOANALYSIS; BIOLOGICAL MATRIXES; INTERNAL STANDARDS; INTERNAL STARDARD; ISOTOPIC LABELING; LARGE-SCALE ANALYSIS; LC-MS-MS; LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY; PEPTIDOMICS;

PEPTIDES;

PEPTIDE DERIVATIVE; REAGENT;

ACCURACY; BODY FLUID; HUMAN; LIQUID CHROMATOGRAPHY; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDOMICS; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARD; TANDEM MASS SPECTROMETRY;

EID: 84864005813     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2757     Document Type: Review

References (110)

1. Ahmed FE. Utility of mass spectrometry for proteome analysis: part II. Ion-activation methods, statistics, bioinformatics and annotation. Expert Review of Proteomics 2009; 6(2): 171-197.
2. Andrews GL, Simons BL, Young JB, Hawkridge AM, Muddiman DC. Performance characteristics of a new hybrid quadrupole time-of-flight tandem mass spectrometer (TripleTOF 5600). Analytical Chemistry 2011; 83(13): 5442-5446.
3. Araki Y, Nonaka D, Tajima A, Maruyama M, Nitto T, Ishikawa H, Yoshitake H, Yoshida E, Kuronaka N, Asada K, Yanagida M, Nojima M, Yoshida K, Takamori K, Hashiguchi T, Maruyama I, Lee LJ and Tanaka K. Quantitative peptidomic analysis by a newly developed one-step direct transfer technology without depletion of major blood proteins: its potential utility for monitoring of pathophysiological status in pregnancy-induced hypertension. Proteomics 2011; 11(13): 2727-2737.
4. Armenta JM, Perez M, Yang X, Shapiro D, Reed D, Tuli L, Finkielstein CV and Lazar IM. Fast proteomic protocol for biomarker fingerprinting in cancerous cells. Journal of Chromatography. A 2010; 1217(17): 2862-2870.
5. Baggerman G, Verleyen P, Clynen E, Huybrechts J, De Loof A and Schoofs L. Peptidomics. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2004; 803(1): 3-16.
6. Becker GW. Stable isotopic labeling of proteins for quantitative proteomic applications. Briefing in Function Genomic and Proteomic 2008; 7(5): 371-382.
7. Bennett S, Grant M, Creese AJ, Mangialasche F, Cecchetti R, Cooper HJ, Mecocci P and Aldred S. Plasma levels of complement 4a protein are increased in Alzheimer's disease. Alzheimer Disease and Associate Disorders 2011; in press. doi: 10.1097/WAD.0b013e318239dcbd.
8. Berman Y, Ageyeva L, Veksler B, Wood D and Devi LA. Dynorphin A processing enzyme: tissue distribution, isolation, and characterization. Journal of Biochemistry 1999; 125(3): 641-647.
9. Bousquet-Dubouch MP, Fabre B, Monsarrat B and Burlet-Schiltz O. Proteomics to study the diversity and dynamics of proteasome complexes: from fundamentals to the clinic. Expert Review of Proteomics 2011; 8(4): 459-481.
10. Bronsema KJ, Bischoff R and van de Merbel NC. Internal standards in the quantitative determination of protein biopharmaceuticals using liquid chromatography coupled to mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2012; 893-894: 1-14.
11. Burkhart JM, Vaudel M, Zahedi RP, Martens L and Sickmann A. iTRAQ protein quantification: a quality-controlled workflow. Proteomics 2011; 11(6): 1125-1134.
12. Cairns DA. Statistical issues in quality control of proteomic analyses: good experimental design and planning. Proteomics 2011; 11(6): 1037-1048.
13. Cappadona S, Muñoz J, Spee WP, Low TY, Mohammed S, van Breukelen B and Heck AJ. Deconvolution of overlapping isotopic clusters improves quantification of stable isotope-labeled peptides. Journal of Proteomics 2011; 74(10): 2204-2209.
14. Chakraborty A and Regnier FE. Global internal standard technology for comparative proteomics. Journal of Chromatography. A 2002; 949(1-2): 173-184.
15. Chalkley R. Instrumentation for LC-MS/MS in proteomics. Methods in Molecular Biology 2010; 658: 47-60.
16. Chautard E, Thierry-Mieg N and Ricard-Blum S. Interaction networks: from protein functions to drug discovery. A review. Pathologie-Biologue 2009; 57(4): 324-333.
17. Che FY, Biswas R and Fricker LD. Relative quantitation of peptides in wild-type and Cpe(fat/fat) mouse pituitary using stable isotopic tags and mass spectrometry. Journal of Mass Spectrometry 2005; 40(2): 227-237.
18. Chen X, Sun L, Yu Y, Xue Y and Yang P. Amino acid-coded tagging approaches in quantitative proteomics. Expert Review of Proteomics 2007; 4(1): 25-37.
19. Chiappetta G, Ndiaye S, Demey E, Haddad I, Marino G, Amoresano A and Vinh J. Dansyl-peptides matrix-assisted laser desorption/ionization mass spectrometric (MALDI-MS) and tandem mass spectrometric (MS/MS) features improve the liquid chromatography/MALDI-MS/MS analysis of the proteome. Rapid Communication in Mass Spectrometry 2010; 24(20): 3021-3032.
20. Cox J and Mann M. Quantitative, high-resolution proteomics for data-driven systems biology. Annual Review of Biochemistry 2011; 80: 273-299.
21. DeSouza LV, Taylor AM, Li W, Minkoff MS, Romaschin AD, Colgan TJ and Siu KW. Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues. Journal of Proteome Research 2008; 7(8): 3525-3534.
22. DeSouza LV, Krakovska O, Darfler MM, Krizman DB, Romaschin AD, Colgan TJ and Siu KW. mTRAQ-based quantification of potential endometrial carcinoma biomarkers from archived formalin-fixed paraffin-embedded tissues. Proteomics 2010; 10(17): 3108-3116.
23. Ernoult E, Gamelin E and Guette C. Improved proteome coverage by using iTRAQ labelling and peptide OFFGEL fractionation. Proteome Science 2008; 6: 27.
24. Ferranti P, Nasi A, Bruno M, Basile A, Serpe L and Gallo P. A peptidomic approach for monitoring and characterising peptide cyanotoxins produced in Italian lakes by matrix-assisted laser desorption/ionisation and quadrupole time-of-flight mass spectrometry. Rapid Communication in Mass Spectrometry 2011; 25(9): 1173-1183.
25. Fortin T, Salvador A, Charrier JP, Lenz C, Bettsworth F, Lacoux X, Choquet-Kastylevsky G and Lemoine J. Multiple reaction monitoring cubed for protein quantification at the low nanogram/milliliter level in nondepleted human serum. Analytical Chemistry 2009; 81(22): 9343-9352.
26. Friedman DB. Assessing signal-to-noise in quantitative proteomics: multivariate statistical analysis in DIGE experiments. Methods in Molecular Biology 2012; 854: 31-45.
27. Gonnelli G, Hulstaert N, Degroeve S and Martens L. Towards a human proteomics atlas. Analytical and Bioanalytical Chemistry 2012, in press.
28. Goodlett DR, Keller A, Watts JD, Newitt R, Yi EC, Purvine S, Eng JK, von Haller P, Aebersold R and Kolker E. Differential stable isotope labeling of peptides for quantitation and de novo sequence derivation. Rapid Communication in Mass Spectrometry 2001; 15(14): 1214-1221.
29. de Graaf EL, Altelaar AF, van Breukelen B, Mohammed S and Heck AJ. Improving SRM assay development: a global comparison between triple quadrupole, ion trap, and higher energy CID peptide fragmentation spectra. Journal of Proteome Research 2011; 10(9): 4334-4341.
30. Guillarme D, Ruta J, Rudaz S and Veuthey JL. New trends in fast and high-resolution liquid chromatography: a critical comparison of existing approaches. Analytical and Bioanalytical Chemistry 2010; 397(3): 1069-1082.
31. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnology 1999; 17(10): 994-999.
32. Halquist MS and Karnes HT. Quantitative liquid chromatography tandem mass spectrometry analysis of macromolecules using signature peptides in biological fluids. Biomedical Chromatography 2011; 25(1-2): 47-58.
33. Hamdan M and Righetti PG. Modern strategies for protein quantification in proteome analysis: advantages and limitations. Mass Spectrometry Review 2002; 21(4): 287-302.
34. Honour JW. Development and validation of a quantitative assay based on tandem mass spectrometry. Annuals of Clinical Biochemistry 2011; 48(2): 97-111.
35. Hoofnagle AN. Quantitative clinical proteomics by liquid chromatography-tandem mass spectrometry: assessing the platform. Clinical Chemistry 2010; 56(2): 161-164.
36. Hoofnagle AN, Becker JO, Oda MN, Cavigiolio G, Mayer P and Vaisar T. Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures. Clinical Chemistry 2012; 58(4): 777-781.
37. Hook V, Funkelstein L, Lu D, Bark S, Wegrzyn J and Hwang SR. Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. Annual Review of Pharmacology and Toxicology 2008; 48: 393-423.
38. Issaq HJ, Chan KC, Blonder J, Ye X and Veenstra TD. Separation, detection and quantitation of peptides by liquid chromatography and capillary electrochromatography. Journal of Chromatography. A 2009; 1216(10): 1825-1837.
39. Jørgensen JT. A challenging drug development process in the era of personalized medicine. Drug Discovery Today 2011; 16(19-20): 891-897.
40. Julka S and Regnier F. Quantification in proteomics through stable isotope coding: a review. Journal of Proteome Research 2004; 3(3): 350-363.
41. Kamath KS, Vasavada MS and Srivastava S. Proteomic databases and tools to decipher post-translational modifications. Journal of Proteomics 2011; 75(1): 127-144.
42. Kato K, Jingu S, Ogawa N and Higuchi S. Determination of pibutidine metabolites in human plasma by LC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis 2000; 24(2): 237-249.
43. Koehler CJ, Strozynski M, Kozielski F, Treumann A and Thiede B. Isobaric peptide termini labeling for MS/MS-based quantitative proteomics. Journal of Proteome Research 2009; 8(9): 4333-4341.
44. Korfmacher WA. Principles and applications of LC-MS in new drug discovery. Drug Discovery Today 2005; 10(20): 1357-1367.
45. Kuepper U, Musshoff F, Hilger RA, Herbstreit F and Madea B. Pharmacokinetic properties of succinylmonocholine in surgical patients. Journal of Analytical Toxicology 2011; 35(5): 302-311.
46. Kuhara T. Noninvasive human metabolome analysis for differential diagnosis of inborn errors of metabolism. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2007; 855(1): 42-50.
47. Kuhn E, Whiteaker JR, Mani DR, Jackson AM, Zhao L, Pope ME, Smith D, Rivera KD, Anderson NL, Skates SJ, Pearson TW, Paulovich AG and Carr SA. Inter-laboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma. Molecular & Cellular Proteomics 2011, in press.
48. Kumar C, Mann M. Bioinformatics analysis of mass spectrometry-based proteomics data sets. FEBS Letters 2009; 583: 1703-1712.
49. Lanckmans K, Sarre S, Smolders I and Michotte Y. Use of a structural analogue versus a stable isotope labeled internal standard for the quantification of angiotensin IV in rat brain dialysates using nano-liquid chromatography/tandem mass spectrometry. Rapid Communication in Mass Spectrometry 2007; 21(7): 1187-1195.
50. Lebert D, Dupuis A, Garin J, Bruley C and Brun V. Production and use of stable isotope-labeled proteins for absolute quantitative proteomics. Methods in Molecular Biology 2011; 753: 93-115.
51. Lee JW and Hall M. Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2009; 877(13): 1259-1271.
52. Lee MS and Kerns EH. LC/MS applications in drug development. Mass Spectrometry Reviews 1999; 18(3-4): 187-279.
53. Lee JW, Hulse JD and Colburn WA. Surrogate biochemical markers: precise measurement for strategic drug and biologics development. Journal of Clinical Pharmacology 1995; 35(5): 464-470.
54. Lee JM, Han JJ, Altwerger G and Kohn EC. Proteomics and biomarkers in clinical trials for drug development. Journal of Proteomics 2011; 74(12): 2632-2641.
55. Levin Y. The role of statistical power analysis in quantitative proteomics. Proteomics 2011; 11(12): 2565-2567.
56. Lill J. Proteomic tools for quantitation by mass spectrometry. Mass Spectrometry Reviews 2003; 22(3): 182-194.
57. Mangerini R, Romano P, Facchiano A, Damonte G, Muselli M, Rocco M, Boccardo F and Profumo A. The application of atmospheric pressure matrix-assisted laser desorption/ionization to the analysis of long-term cryopreserved serum peptidome. Analatycal Biochemistry 2011; 417(2): 174-181.
58. Mirzaei H, Brusniak MY, Mueller LN, Letarte S, Watts JD and Aebersold R. Halogenated peptides as internal standards (H-PINS): introduction of an MS-based internal standard set for liquid chromatography-mass spectrometry. Molecular & Cellular Proteomics 2009; 8(8): 1934-1946.
59. Mulvana DE. Critical topics in ensuring data quality in bioanalytical LC-MS method development. Bioanalysis 2010; 2(6): 1051-1072.
60. Nakahara Y, Takahashi K, Shimamine M and Takeda Y. Hair analysis for drug abuse: I. Determination of methamphetamine and amphetamine in hair by stable isotope dilution gas chromatography/mass spectrometry method. Journal of Forensic Science 1991; 36(1): 70-78.
61. Nam HW, Simpson R and Kim YS. N-terminal isotope tagging with propionic anhydride: proteomic analysis of myogenic differentiation of C2C12 cells. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2005; 826(1-2): 91-107.
62. Neilson KA, Ali NA, Muralidharan S, Mirzaei M, Mariani M, Assadourian G, Lee A, van Sluyter SC and Haynes PA. Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 2011; 11(4): 535-553.
63. Nogueira FC, Palmisano G, Schwämmle V, Campos FA, Larsen MR, Domont G and Roepstorff P. Performance of isobaric and isotopic labeling in quantitative plant proteomics. Journal of Proteome Research 2012; 11(5): 3046-3052.
64. Ohtsuki S, Uchida Y, Kubo Y and Terasaki T. Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects. Journal of Pharmaceutical Science 2011; 100(9): 3547-3559.
65. Ong SE and Mann M. Mass spectrometry-based proteomics turns quantitative. Nature Chemical Biology 2005; 1(5): 252-262.
66. Ow SY, Salim M, Noirel J, Evans C and Wright PC. Minimising iTRAQ ratio compression through understanding LC-MS elution dependence and high-resolution HILIC fractionation. Proteomics 2011; 11(11): 2341-2346.
67. Pailleux F, Lemoine J and Beaudry F. Investigation of the metabolic biotransformation of substance P in liver microsomes by liquid chromatography quadrupole ion trap mass spectrometry. Biomedical Chormatography 2012. DOI: 10.1002/bmc.2746.
68. Palagi PM, Hernandez P, Walther D and Appel RD. Proteome informatics I: bioinformatics tools for processing experimental data. Proteomics 2006; 6(20): 5435-5444.
69. Pan S and Aebersold R. Quantitative proteomics by stable isotope labeling and mass spectrometry. Methods in Molecular Biolology 2007; 367: 209-218.
70. Pawar H, Kashyap MK, Sahasrabuddhe NA, Renuse S, Harsha HC, Kumar P, Sharma J, Kandasamy K, Marimuthu A, Nair B, Rajagopalan S, Maharudraiah J, Premalatha CS, Kumar KV, Vijayakumar M, Chaerkady R, Prasad TS, Kumar RV, Kumar RV and Pandey A. Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery. Cancer Biology & Therapy 2011; 12(6): 510-522.
71. Peters EC, Horn DM, Tully DC and Brock A. A novel multifunctional labeling reagent for enhanced protein characterization with mass spectrometry. Rapid Communication in Mass Spectrometry 2001; 15(24): 2387-2392.
72. Picotti P, Bodenmiller B, Mueller LN, Domon B and Aebersold R. Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 2009; 138(4): 795-806.
73. Picotti P, Rinner O, Stallmach R, Dautel F, Farrah T, Domon B, Wenschuh H and Aebersold R. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes. Nature Methods 2010; 7(1): 43-46.
74. Plumb RS, Fujimoto G, Mather J, Potts WB, Rainville PD, Ellor NJ, Evans C, Kehler JR and Szapacs ME. Comparison of the quantification of a therapeutic protein using nominal and accurate mass MS/MS. Bioanalysis 2012; 4(5): 605-615.
75. Podwojski K, Eisenacher M, Kohl M, Turewicz M, Meyer HE, Rahnenführer J and Stephan C. Peek a peak: a glance at statistics for quantitative label-free proteomics. Expert Review of Proteomics 2010; 7(2): 249-261.
76. Quaglia M, Pritchard C, Hall Z and O'Connor G. Amine-reactive isobaric tagging reagents: requirements for absolute quantification of proteins and peptides. Analytical Biochemistry 2008; 379(2): 164-169.
77. Regnier FE and Julka S. Primary amine coding as a path to comparative proteomics. Proteomics 2006; 6(14): 3968-3979.
78. Remane D, Wissenbach DK, Meyer MR and Maurer HH. Systematic investigation of ion suppression and enhancement effects of fourteen stable-isotope-labeled internal standards by their native analogues using atmospheric-pressure chemical ionization and electrospray ionization and the relevance for multi-analyte liquid chromatographic/mass spectrometric procedures. Rapid Commununication in Mass Spectrometry 2010; 24(7): 859-867.
79. Romanyshyn LA and Tiller PR. Ultra-short columns and ballistic gradients: considerations for ultra-fast chromatographic liquid chromatographic-tandem mass spectrometric analysis. Journal of Chromatography. A 2001; 928(1): 41-51.
80. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, Purkayastha S, Juhasz P, Martin S, Bartlet-Jones M, He F, Jacobson A and Pappin DJ. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Molecular & Cellular Proteomics 2004; 3(12): 1154-1169.
81. Sandra K, Moshir M, D'hondt F, Verleysen K, Kas K and Sandra P. Highly efficient peptide separations in proteomics Part 1. Unidimensional high performance liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2008; 866(1-2): 48-63.
82. Schiess R, Wollscheid B and Aebersold R. Targeted proteomic strategy for clinical biomarker discovery. Molecular Oncology 2009; 3(1): 33-44.
83. Schrader M and Selle H. The process chain for peptidomic biomarker discovery. Disease Markers 2006; 22(1-2): 27-37.
84. Sechi S and Chait BT. Modification of cysteine residues by alkylation. A tool in peptide mapping and protein identification. Analytical Chemistry 1998; 70(24): 5150-5158.
85. Selevsek N, Matondo M, Sanchez Carbayo M, Aebersold R and Domon B. Systematic quantification of peptides/proteins in urine using selected reaction monitoring. Proteomics 2011; 11(6): 1135-1147.
86. Shushan B. A review of clinical diagnostic applications of liquid chromatography-tandem mass spectrometry. Mass Spectrometry Reviews 2010; 29(6): 930-944.
87. Soloviev M and Finch P. Peptidomics: bridging the gap between proteome and metabolome. Proteomics 2006; 6(3): 744-747.
88. Stokvis E, Rosing H and Beijnen JH. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Rapid Communication in Mass Spectrometry 2005; 19(3): 401-407.
89. Tabata T, Sato T, Kuromitsu J and Oda Y. Pseudo internal standard approach for label-free quantitative proteomics. Analytical Chemistry 2007; 79(22): 8440-8445.
90. Tamvakopoulos C. Mass spectrometry for the quantification of bioactive peptides in biological fluids. Mass Spectrometry Reviews 2007; 26(3): 389-402.
91. Thomas A, Solymos E, Schänzer W, Baume N, Saugy M, Dellanna F and Thevis M. Determination of Vasopressin and Desmopressin in urine by means of liquid chromatography coupled to quadrupole time-of-flight mass spectrometry for doping control purposes. Analytica Chimica Acta 2011; 707(1-2): 107-113.
92. Thompson A, Schäfer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, Neumann T, Johnstone R, Mohammed AK and Hamon C. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Analytical Chemistry 2003; 75(8): 1895-1904.
93. Tinoco AD, Kim YG, Tagore DM, Wiwczar J, Lane WS, Danial NN and Saghatelian A. A peptidomics strategy to elucidate the proteolytic pathways that inactivate peptide hormones. Biochemistry 2011; 50(12): 2213-2222.
94. Trist DG. Scientific process, pharmacology and drug discovery. Current Opinion in Pharmacology 2011; 11(5): 528-533.
95. Walther DM and Mann M. Accurate quantification of more than 4000 mouse tissue proteins reveals minimal proteome changes during aging. Molecular & Cellular Proteomics 2011; 10(2): M110.004523.
96. Wang M and You J. Mass spectrometry for protein quantification in biomarker discovery. Methods in Molecular Biology 2012; 815: 199-225.
97. Wang S, Cyronak M and Yang E. Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. Journal of Pharmaceutical and Biomededical Analysis 2007a; 43(2): 701-707.
98. Wang Y, Chiu JF and He QY. Bioinformatic application in proteomic research on biomarker discovery and drug target validation. Current Bioinformatics 2007b; 2(1): 11-20.
99. Weber SJ, Louis RB, Trombley L, Bissette G, Davies P and Davis TP. Metabolic half-life of somatostatin and peptidase activities are altered in Alzheimer's disease. Journal of Gerontology 1992; 47(1): B18-25.
100. Westwick JK and Lamerdin JE. Improving drug discovery with contextual assays and cellular systems analysis. Methods in Molecular Biology 2011; 756: 61-73.
101. Wieling J. LC-MS-MS experiences with internal standards. Chromatographia 2002; 55(S): S107-S113.
102. Winter D, Seidler J, Kugelstadt D, Derrer B, Kappes B and Lehmann WD. Minimally permutated peptide analogs as internal standards for relative and absolute quantification of peptides and proteins. Proteomics 2010; 10(7): 1510-1514.
103. Wolthers BG and Kraan GP. Clinical applications of gas chromatography and gas chromatography-mass spectrometry of steroids. Journal of Chromatography. A 1999; 843(1-2): 247-274.
104. Xia JQ, Sedransk N and Feng X. Variance component analysis of a multi-site study for the reproducibility of multiple reaction monitoring measurements of peptides in human plasma. PLoS One 2011; 6(1): e14590.
105. Xiang F, Ye H, Chen R, Fu Q and Li L. N, N-dimethyl leucines as novel isobaric tandem mass tags for quantitative proteomics and peptidomics. Analytical Chemistry 2010; 82(7): 2817-2825.
106. Ye X, Blonder J and Veenstra TD. Targeted proteomics for validation of biomarkers in clinical samples. Briefing in Functional Genomic and Proteomic 2009; 8(2): 126-135.
107. Yokokawa A, Yamamoto K, Omori Y, Shibasaki H, Shinohara Y, Kasuya Y and Furuta T. Simultaneous determination of androstenedione, 11beta-hydroxyandrostenedione, and testosterone in human plasma by stable isotope dilution mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2009; 877(7): 621-626.
108. Zhang X, Petruzziello F, Zani F, Fouillen L, Andren PE, Solinas G and Rainer G. High identification rates of endogenous neuropeptides from mouse brain. Journal of Proteome Research 2012a; 11(5): 2819-2827.
109. Zhang X, Yin X, Yu H, Liu X, Yang F, Yao J, Jin H and Yang P. Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. Analyst 2012b; 137(2): 490-495.
110. Zhu W, Smith JW and Huang CM. Mass spectrometry-based label-free quantitative proteomics. Journal of Biomedicine and Biotechnology 2010; 2010: 6. DOI: 10.1155/2010/840518.